Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Rucaparib MAintenance After Bevacizumab Maintenance Following Carboplatin Based First Line Chemotherapy in Ovarian Cancer Patients

NCT04227522 is registered in ClinicalTrials.gov with North Eastern German Society of Gynaecological Oncology as lead sponsor.

NCT NCT04227522
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04227522 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Rucaparib MAintenance After Bevacizumab Maintenance Following Carboplatin Based First Line Chemotherapy in Ovarian Cancer Patients
Lead sponsor
North Eastern German Society of Gynaecological Oncology
Phase
Phase 3
Overall status
Completed
Start date
June 8, 2020
Completion date
July 1, 2024
Enrollment
42 (actual)
Sites
17

Conditions

As the registry lists them; a condition with its own page is linked.

clear cell carcinoma, fallopian tube cancer, ovarian cancer, primary peritoneal cancer